scholarly article | Q13442814 |
P356 | DOI | 10.1158/1078-0432.CCR-10-0166 |
P698 | PubMed publication ID | 21177409 |
P2093 | author name string | Jaume Reventós | |
Josep Roma | |||
Soledad Gallego | |||
Josep Sánchez de Toledo | |||
Anna Masià | |||
P2860 | cites work | Critical role of notch signaling in osteosarcoma invasion and metastasis | Q39352960 |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | neoplastic invasiveness | Q112498967 |
rhabdomyosarcoma | Q1898141 | ||
P304 | page(s) | 505-513 | |
P577 | publication date | 2010-12-21 | |
P1433 | published in | Clinical Cancer Research | Q332253 |
P1476 | title | Notch pathway inhibition significantly reduces rhabdomyosarcoma invasiveness and mobility in vitro | |
P478 | volume | 17 |
Q47782462 | A Novel Notch-YAP Circuit Drives Stemness and Tumorigenesis in Embryonal Rhabdomyosarcoma |
Q93188577 | Comparison of cachectic and non-cachectic sarcoma patients reveals an important role of Notch signaling in metastasis and myogenesis |
Q36888312 | Dual Pten/Tp53 suppression promotes sarcoma progression by activating Notch signaling |
Q30426842 | Embryonic signaling pathways and rhabdomyosarcoma: contributions to cancer development and opportunities for therapeutic targeting |
Q39144774 | Failure to downregulate the BAF53a subunit of the SWI/SNF chromatin remodeling complex contributes to the differentiation block in rhabdomyosarcoma. |
Q39277802 | HES6 enhances the motility of alveolar rhabdomyosarcoma cells. |
Q38834036 | Hedgehog/Patched-associated rhabdomyosarcoma formation from delta1-expressing mesodermal cells |
Q36546768 | Hes1 triggers epithelial-mesenchymal transition (EMT)-like cellular marker alterations and promotes invasion and metastasis of nasopharyngeal carcinoma by activating the PTEN/AKT pathway |
Q33567866 | Hyper-activation of Notch3 amplifies the proliferative potential of rhabdomyosarcoma cells. |
Q91876352 | Identification of tumorigenicity-associated genes in osteosarcoma cell lines based on bioinformatic analysis and experimental validation |
Q37378867 | Inflammatory stress and sarcomagenesis: a vicious interplay |
Q30427044 | Inhibition of Notch3 signalling induces rhabdomyosarcoma cell differentiation promoting p38 phosphorylation and p21(Cip1) expression and hampers tumour cell growth in vitro and in vivo. |
Q35622015 | Inhibition of the Notch-Hey1 axis blocks embryonal rhabdomyosarcoma tumorigenesis |
Q34475754 | Initial testing (stage 1) of the notch inhibitor PF-03084014, by the pediatric preclinical testing program |
Q34267924 | New therapeutic targets in soft tissue sarcoma |
Q34480012 | Notch signaling in pediatric soft tissue sarcomas |
Q28072977 | Notch signalling pathway as an oncogenic factor involved in cancer development |
Q42153919 | Notch, wnt, and hedgehog pathways in rhabdomyosarcoma: from single pathways to an integrated network |
Q39279019 | Notch-mediated induction of N-cadherin and α9-integrin confers higher invasive phenotype on rhabdomyosarcoma cells |
Q26858778 | Notch: a key regulator of tumor angiogenesis and metastasis |
Q37001697 | Oncogenic role of the Notch pathway in primary liver cancer. |
Q38105879 | Proof-of-concept rare cancers in drug development: the case for rhabdomyosarcoma. |
Q34335672 | RBPJ is a novel target for rhabdomyosarcoma therapy |
Q35828593 | SRC family kinase (SFK) inhibition reduces rhabdomyosarcoma cell growth in vitro and in vivo and triggers p38 MAP kinase-mediated differentiation |
Q58707604 | Soft Tissue Sarcoma Cancer Stem Cells: An Overview |
Q26770333 | Spanning the genomics era: the vital role of a single institution biorepository for childhood cancer research over a decade |
Q21285014 | Targeted therapies in sarcomas: challenging the challenge |
Q38671086 | The NOTCH1/SNAIL1/MEF2C Pathway Regulates Growth and Self-Renewal in Embryonal Rhabdomyosarcoma |
Q38211082 | The role of inflammation in sarcoma |
Q37931268 | Therapeutic pipeline for soft-tissue sarcoma |
Search more.